Document Detail


Cisplatin application in pregnancy: first in vivo analysis of 7 patients.
MedLine Citation:
PMID:  21071993     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cervical cancer in pregnancy is an oncologic challenge. Empirical cisplatin is recommended to prevent cancer progression until fetal maturity. Seven patients with cervical cancer in the second trimester decided to delay delivery together with neoadjuvant chemotherapy. After 2-4 cycles, caesarean section and radical hysterectomy were performed above 32 weeks of gestation. Synchronous samples from maternal blood, umbilical cord blood and amniotic fluid were taken. All patients delivered healthy babies. Cisplatin concentrations in umbilical cord and amniotic fluid were 31-65 and 13-42% of the maternal blood, respectively. This is the first series on in vivo cisplatin concentration in the fetomaternal compartment.
Authors:
Simone Marnitz; Christhardt Köhler; Peter Oppelt; Alexander Schmittel; Giovanni Favero; Kati Hasenbein; Achim Schneider; Maurie Markman
Related Documents :
6388223 - The infrequent occurrence of mycoplasmas in amniotic fluid from women with intact fetal...
1058283 - New concept of morphogenesis of clefts in the lip, alveolus, and palate.
11744943 - Teenage pregnancy.
Publication Detail:
Type:  Journal Article     Date:  2010-11-12
Journal Detail:
Title:  Oncology     Volume:  79     ISSN:  1423-0232     ISO Abbreviation:  Oncology     Publication Date:  2010  
Date Detail:
Created Date:  2011-01-03     Completed Date:  2011-01-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0135054     Medline TA:  Oncology     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  72-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 S. Karger AG, Basel.
Affiliation:
Department of Radiooncology, Campus CCM and CVK, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / drug therapy
Adult
Amniotic Fluid / metabolism
Antineoplastic Agents / blood,  metabolism*,  therapeutic use*
Carcinoma, Squamous Cell / drug therapy
Cesarean Section
Chemotherapy, Adjuvant
Cisplatin / blood,  metabolism*,  therapeutic use*
Female
Fetal Blood / metabolism
Humans
Hysterectomy
Interdisciplinary Communication
Laparoscopy
Lymph Node Excision
Lymphatic Metastasis
Neoadjuvant Therapy / methods*
Neoplasm Staging
Pregnancy
Pregnancy Complications, Neoplastic / blood,  drug therapy*,  metabolism
Pregnancy Trimester, Second
Radiotherapy, Adjuvant
Uterine Cervical Neoplasms / blood,  drug therapy*,  metabolism
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 15663-27-1/Cisplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stop and go FOLFOX plus bevacizumab chemotherapy in the first-line treatment of metastatic colorecta...
Next Document:  Prognostic model to predict outcomes in non-small cell lung cancer patients with erlotinib as salvag...